Biotech grants in Switzerland
Explore Biotech grants for companies in Switzerland. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Swiss innovation agencies, research funders and foundations, international programs open to applicants in Switzerland, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Switzerland come first.
Showing 385-408 of 569 grants
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
CEPI FA2 Exploratory Award
CEPI · Norway
Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.
CEPI FA2 Preclinical Development Award
CEPI · Norway
Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.
Cure CMD Congenital Dystroglycanopathies Research Grant
Cure CMD (Congenital Muscular · United States
Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.
Cure CMD L-CMD Research Grant
Cure CMD (Congenital Muscular · United States
Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.
DeepTech Frontier Challenge 2026
Global Startup EXPO · Japan
Awards a ¥10 million grand prize to deep-tech startups pitching at Global Startup EXPO 2026.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dream Biology Award
IOCB Prague · Czechia
Pays a €10,000 cash prize to an early-career biologist with a bold research vision.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Estimating the Global Burden of Diarrheal Diseases
Gates Foundation · United States
Supports teams producing country-level estimates of major diarrheal diseases to inform global health planning and child health priorities.
FARA RFP: Blood-Based Biomarkers for FA
FARA · United States
Funds biomarker discovery and validation programs supporting translational research in Friedreich ataxia.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Generic Drug Repurposing RFP
Coefficient · United States
Funds late-stage clinical testing of repurposed medicines for neglected diseases.
Global Oncology Young Investigator Award
Conquer Cancer · Global / Multinational
Funds global oncology junior investigators through mentored development and implementation pathways.
Grand Challenges — Breakthrough Innovations to Reduce the Cost of Severe Acute Malnutrition Treatment
Gates Foundation · United States
Funds global teams developing system-level innovations that reduce the total cost of treating severe acute malnutrition in Sub-Saharan Africa and South Asia.
Grand Challenges — Cost-Reducing Innovations for Ready-to-Use Therapeutic Food
Gates Foundation · United States
Funds global teams developing innovations in protein, lipids, packaging, and manufacturing that reduce the ex-factory unit cost of ready-to-use therapeutic food by at least 30%.
Grand Challenges — Placental and Gut Inflammation Interventions for Fetal Growth
Gates Foundation · United States
Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.
Grand Challenges — Ultralow-Cost Diagnostics and Screening for Low-Income Countries
Gates Foundation · United States
Funds global teams developing diagnostic devices and screening tools that cost approximately $1 per test or near-zero incremental cost per person screened for deployment in low-income countries.
Hello Tomorrow Global Challenge (9th Edition)
Hello Tomorrow · Global / Multinational
Pays a 100,000-euro equity-free grand prize to early-stage deep tech startups globally.
HOPE — Execution
Wellcome Leap · United States
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
Impact of Initial Influenza Exposure on Immunity in Infants — RFA-AI-27-019
NIAID · United States
Supports longitudinal infant influenza immunity studies to guide next-generation vaccine design.
In Utero — Execution
Wellcome Leap · United States
Funds United Kingdom stillbirth-reduction initiatives with prenatal intervention and translational implementation support.
Innovations in Decentralized Pan-Orthoebolavirus Diagnostics
Gates Foundation · United States
Funds up to 12 awards, $150K-800K each, for rapid Ebola diagnostic tools.